← FDA DRUG APPROVALS

FDA ANDA · ANDA074176

CIMETIDINE HYDROCHLORIDE

Sponsor: G AND W LABS INC

APPLICATION
ANDA074176
TYPE
ANDA
ORIGINAL APPROVAL
1994-06-01
LATEST ACTION
2000-08-09
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

CIMETIDINE HYDROCHLORIDEDiscontinued
CIMETIDINE HYDROCHLORIDE EQ 300MG BASE/5ML · SOLUTION · ORAL

Approval history

2000-08-09Manufacturing (CMC) · Supplement 7AP
2000-05-26Manufacturing (CMC) · Supplement 6AP
1997-02-10Manufacturing (CMC) · Supplement 4AP
1996-04-24Labeling · Supplement 3AP
1995-02-23Manufacturing (CMC) · Supplement 2AP
1994-11-03Labeling · Supplement 1AP
1994-06-01OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →